Dorsey Wright & Associates Zymeworks Inc. Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020
SELL
$29.21 - $46.58 $11,654 - $18,585
-399 Closed
0 $0
Q1 2020

Apr 20, 2020
SELL
$24.28 - $49.8 $704 - $1,444
-29 Reduced 6.78%
399 $14,000
Q3 2019

Oct 31, 2019
BUY
$22.78 - $29.08 $9,749 - $12,446
428 New
428 $11,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email